Markets:

Overview

News

Currencies

International

Treasuries

23andMe Holding Co. - Common Stock (NQ:ME)

0.6063 UNCHANGED

Last Price Updated: 4:00 PM EDT, Mar 28, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about 23andMe Holding Co. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >

What's going on in today's after hours session ↗

March 31, 2025

After the conclusion of the US market's regular session on Monday, let's examine the after-hours session and unveil the notable performers among the top gainers and losers.

Via Chartmill

12 Health Care Stocks Moving In Friday's After-Market Session ↗

March 28, 2025

Via Benzinga

How to Tune Out Market Noise ↗

March 28, 2025

Via The Motley Fool

Topics Bankruptcy World Trade

These stocks have an unusual volume in today's session ↗

March 28, 2025

Which stocks have an unusual volume on Friday?

Via Chartmill

12 Health Care Stocks Moving In Friday's Intraday Session ↗

March 28, 2025

Via Benzinga

Lifeline For 23andMe? Stock Jumps After Court Greenlights Bankruptcy Asset Sale, Retail Weighs Possible Rescue Deals ↗

March 28, 2025

Stocktwits users spotted a media report about Richard Magides, the director of Singapore-based Zentree Investment and 23andMe's second-largest shareholder, expressing interest in backing a rescue...

Via Stocktwits

Topics Bankruptcy

Top movers in Thursday's session ↗

March 27, 2025

Looking for insights into the US markets one hour before the close of the markets on Thursday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.

Via Chartmill

These stocks are the most active in today's session ↗

March 27, 2025

Stay updated with the latest market activity on Thursday. Explore the most active stocks in today's session and stay informed about the stocks that are in the spotlight.

Via Chartmill

Top stock movements in today's session. ↗

March 27, 2025

Looking for insights into the US markets in the middle of the day on Thursday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.

Via Chartmill

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

March 27, 2025

Via Benzinga

23andMe Confirms All Potential Buyers Must Agree to Comply With Privacy Policy and Applicable Law

March 26, 2025

Receives Court Approval for First Day Motions to Support Ongoing Business Operations

From 23andMe, Inc.

Via GlobeNewswire

Cybersecurity Stocks To Outperform, It's The 'One Line Item That No Company In The World Is Cutting': Josh Brown ↗

March 26, 2025

Cybersecurity is "the one line item that no company in the world is cutting," Brown said, noting how a data breach brought down 23andMe.

Via Benzinga

Topics Data Breach

23andMe's Bankruptcy Sparks Privacy Concerns Over Genetic Database Of 15 Million Customers ↗

March 25, 2025

23andMe files for Chapter 11 bankruptcy, raising concerns about genetic data security as legal challenges emerge over a $30 million data breach settlement.

Via Benzinga

Topics Bankruptcy Data Breach

US Stocks Likely To Open Lower After 2-Day Advance: Clear And Measured Tariff Plan Could 'Trigger A Strong Relief Rally,' Says Expert ↗

March 25, 2025

U.S. stock futures declined on Tuesday, after advancing for two consecutive sessions on Friday and Monday.

Via Benzinga

Microalgo, Palantir, 23Andme, AMD, And Tesla: Why These 5 Stocks Are On Investors' Radars Today ↗

March 24, 2025

The S&P 500 and Nasdaq posted their best gains in months, with the S&P 500 climbing 1.76% to 5,767.57 and the Nasdaq rising 2.3% to 18,188.59.

Via Benzinga

Topics Stocks

What's going on in today's session ↗

March 24, 2025

Keep an eye on the top gainers and losers in Monday's session, as they reflect the most notable price movements.

Via Chartmill

These stocks are moving in today's session ↗

March 24, 2025

Curious to know what's happening on the US markets in the middle of the day on Monday? Join us as we explore the top gainers and losers in today's session.

Via Chartmill

12 Health Care Stocks Moving In Monday's Intraday Session ↗

March 24, 2025

Via Benzinga

Traders are paying attention to the gapping stocks in Monday's session. ↗

March 24, 2025

Traders are paying attention to the gapping stocks in Monday's session. Let's dive into which stocks are experiencing notable gaps.

Via Chartmill

Crude Oil Gains 1%; US Composite PMI Surges In March ↗

March 24, 2025

Via Benzinga

Discover the top movers in Monday's pre-market session. ↗

March 24, 2025

Before the opening bell on Monday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session.

Via Chartmill

Dow Jumps Over 300 Points; Chicago Fed National Activity Index Rises In February ↗

March 24, 2025

Via Benzinga

Topics Economy Stocks

Why Is DNA Test Provider 23andMe Stock Tumbling Today? ↗

March 24, 2025

Shares of 23andMe are falling in premarket trading after the company filed for Chapter 11 bankruptcy to initiate a court-supervised sale process aimed at maximizing business value.

Via Benzinga

Topics Bankruptcy

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

March 24, 2025

Via Benzinga

US Stocks Likely To Open Higher As Trump May Soften Tariff Plans: Analysts Brush Off Bear Hug Fears ↗

March 24, 2025

Stock futures rise on bullish sentiment as Trump administration plans targeted tariffs against trading partners.

Via Benzinga

Topics Government World Trade

Why AZEK Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket ↗

March 24, 2025

Via Benzinga

23andMe Initiates Voluntary Chapter 11 Process to Maximize Stakeholder Value Through Court-Supervised Sale Process

March 23, 2025

From 23andMe, Inc.

Via GlobeNewswire

23andMe Launches New Homocysteine (MTHFR-Related) Genetic Report and Accompanying Lab Test

March 21, 2025

Provides 23andMe+ Premium members with highly requested insight into their likelihood of developing slightly elevated homocysteine levels

From 23andMe, Inc.

Via GlobeNewswire

23andMe Special Committee Rejects Acquisition Proposal From CEO Anne Wojcicki

March 03, 2025

From 23andMe, Inc.

Via GlobeNewswire

Monday's pre-market session: top gainers and losers ↗

March 03, 2025

Before the opening bell on Monday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session.

Via Chartmill

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.